Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

about

Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.Searching for novel biomarkers using a mouse model of CLN3-Batten disease

P2860

Q40158098-96A8BB6E-93D6-484C-937A-D4BFFCDBF8DE Q58797972-A9133510-9336-4523-9451-AD197B2BDF97

P2860

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

Item

http://www.wikidata.org/entity/Q37561375

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

@en

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease

@nl

type

Item

label

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

@en

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease

@nl

prefLabel

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

@en

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease

@nl

P1476

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3)

@en

P2093

Amy Aldrich

http://www.w3.org/2001/XMLSchema#string

Jessica Odvody

http://www.w3.org/2001/XMLSchema#string

Kakulavarapu V Rama Rao

http://www.w3.org/2001/XMLSchema#string

Maria Burkovetskaya

http://www.w3.org/2001/XMLSchema#string

Megan E Bosch

http://www.w3.org/2001/XMLSchema#string

Rachel Fallet

http://www.w3.org/2001/XMLSchema#string

Tammy Kielian

http://www.w3.org/2001/XMLSchema#string

P2860

A call for transparent reporting to optimize the predictive value of preclinical research

Clarifying lysosomal storage diseases

Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis

Phosphodiesterases in the CNS: targets for drug development

Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium

High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease

Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease)

Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system

Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system

A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses.

P304

909-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24815

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan D. Cooper

Arlene Drack

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27804148

http://www.w3.org/2001/XMLSchema#string

P932

5215570

http://www.w3.org/2001/XMLSchema#string

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

about

P2860

P2860

Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932